{"transactions":[{"id":695789,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":false,"shares":1088986.3,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By MVIL, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Notes were scheduled to mature on September 17, 2027, but converted automatically upon the closing of the IPO on August 3, 2026, prior to the maturity date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents securities held by MVIL, LLC."}],"balance_after":0,"derivative":{"exercise_price":14.4,"underlying":"Class A Common Stock","underlying_shares":75624},"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695788,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Preferred Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":false,"shares":9227454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of convertible preferred stock (\"Convertible Preferred Stock\") was convertible into one share of Class A common stock (\"Class A Common Stock\") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of convertible preferred stock (\"Convertible Preferred Stock\") was convertible into one share of Class A common stock (\"Class A Common Stock\") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of convertible preferred stock (\"Convertible Preferred Stock\") was convertible into one share of Class A common stock (\"Class A Common Stock\") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6840213},"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695787,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"other","planned":false,"acquired":true,"shares":75624,"ownership":{"direct":false,"nature":"By MVIL, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents securities held by MVIL, LLC."}],"balance_after":75624,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695786,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"other","planned":false,"acquired":false,"shares":75624,"ownership":{"direct":false,"nature":"By MVIL, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents securities held by MVIL, LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695785,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":true,"shares":75624,"price":14.4,"value":1088985.6,"ownership":{"direct":false,"nature":"By MVIL, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents securities held by MVIL, LLC."}],"balance_after":75624,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695784,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":312500,"price":16,"value":5000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."}],"balance_after":7152713,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695783,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"other","planned":false,"acquired":true,"shares":6840213,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."}],"balance_after":6840213,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695782,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"other","planned":false,"acquired":false,"shares":6840213,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695781,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":true,"shares":6840213,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of convertible preferred stock (\"Convertible Preferred Stock\") was convertible into one share of Class A common stock (\"Class A Common Stock\") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."}],"balance_after":6840213,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":1802971,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-08-17T23:08:14.000Z","date":"2023-08-15","kind":"gift","planned":false,"acquired":false,"shares":3500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL."}],"balance_after":1947993,"source":{"system":"sec-edgar","filing":"0000950170-23-043301","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000095017023043301/ownership.xml","form_type":"4"}},{"id":1803576,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-08-17T21:34:18.000Z","date":"2023-08-15","kind":"gift","planned":false,"acquired":false,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL."}],"balance_after":4997302,"source":{"system":"sec-edgar","filing":"0000899243-23-018211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323018211/doc4.xml","form_type":"4"}},{"id":1823406,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-25T20:01:30.000Z","date":"2023-07-24","kind":"other","planned":false,"acquired":false,"shares":16919155,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 15,919,155 shares of common stock held directly by Morningside Venture Investments Limited and 1,000,000 shares of common stock held by MVIL, LLC, its wholly owned subsidiary."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the merger of the Issuer with a wholly owned subsidiary of SW ParentCo, Inc. (\"Parent\"), the Reporting Persons entered into a Contribution and Exchange Agreement pursuant to which, on July 21, 2023, they contributed all of their shares of the Issuer's common stock to Parent in exchange for shares of preferred stock of Parent."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"In connection with the merger of the Issuer with a wholly owned subsidiary of SW ParentCo, Inc. (\"Parent\"), the Reporting Persons entered into a Contribution and Exchange Agreement pursuant to which, on July 21, 2023, they contributed all of their shares of the Issuer's common stock to Parent in exchange for shares of preferred stock of Parent."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-23-034397","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000095017023034397/ownership.xml","form_type":"4"}},{"id":1933932,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-31T20:05:11.000Z","date":"2023-03-29","kind":"sale","planned":false,"acquired":false,"shares":29048,"price":30.45,"value":884511.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.09 to $31.06, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":6997302,"source":{"system":"sec-edgar","filing":"0000899243-23-010078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323010078/doc4.xml","form_type":"4"}},{"id":1935700,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-29T20:05:31.000Z","date":"2023-03-28","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":30.37,"value":3037000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.06 to $30.86, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7026350,"source":{"system":"sec-edgar","filing":"0000899243-23-009972","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323009972/doc4.xml","form_type":"4"}},{"id":1935699,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-29T20:05:31.000Z","date":"2023-03-27","kind":"sale","planned":false,"acquired":false,"shares":28000,"price":30.8,"value":862400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.74 to $30.88, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7126350,"source":{"system":"sec-edgar","filing":"0000899243-23-009972","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323009972/doc4.xml","form_type":"4"}},{"id":1935698,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-29T20:05:31.000Z","date":"2023-03-27","kind":"sale","planned":false,"acquired":false,"shares":32964,"price":30.25,"value":997161.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.67 to $30.65, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7154350,"source":{"system":"sec-edgar","filing":"0000899243-23-009972","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323009972/doc4.xml","form_type":"4"}},{"id":1940159,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-23T20:05:14.000Z","date":"2023-03-21","kind":"sale","planned":false,"acquired":false,"shares":28807,"price":32.17,"value":926721.19,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.005 to $32.38, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7187314,"source":{"system":"sec-edgar","filing":"0000899243-23-009506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323009506/doc4.xml","form_type":"4"}},{"id":1940158,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-23T20:05:14.000Z","date":"2023-03-21","kind":"sale","planned":false,"acquired":false,"shares":34641,"price":31.69,"value":1097773.29,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $32.00, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7216121,"source":{"system":"sec-edgar","filing":"0000899243-23-009506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323009506/doc4.xml","form_type":"4"}},{"id":1946997,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-17T20:05:09.000Z","date":"2023-03-16","kind":"sale","acquired":false,"shares":9122,"price":32.55,"value":296921.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.50 to $32.93, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7250762,"source":{"system":"sec-edgar","filing":"0000899243-23-008858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323008858/doc4.xml","form_type":"4"}},{"id":1950032,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-16T20:11:53.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":41066,"price":33.68,"value":1383102.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.505 to $34.460, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7259884,"source":{"system":"sec-edgar","filing":"0000899243-23-008733","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323008733/doc4.xml","form_type":"4"}},{"id":1950031,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-16T20:11:53.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":108934,"price":33.12,"value":3607894.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.5 to $33.5, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7300950,"source":{"system":"sec-edgar","filing":"0000899243-23-008733","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323008733/doc4.xml","form_type":"4"}},{"id":1950030,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-16T20:11:53.000Z","date":"2023-03-14","kind":"sale","acquired":false,"shares":70714,"price":34.54,"value":2442461.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.50 to $34.88, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7409884,"source":{"system":"sec-edgar","filing":"0000899243-23-008733","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323008733/doc4.xml","form_type":"4"}},{"id":1969099,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-06T14:10:38.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":50000,"price":33.75,"value":1687500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.38 to $34.04, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7480598,"source":{"system":"sec-edgar","filing":"0000899243-23-007120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323007120/doc4.xml","form_type":"4"}},{"id":1987023,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-28T21:06:25.000Z","date":"2023-02-22","kind":"sale","acquired":false,"shares":2112,"price":35.34,"value":74638.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.28 to $35.45, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7530598,"source":{"system":"sec-edgar","filing":"0000899243-23-006394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323006394/doc4.xml","form_type":"4"}},{"id":1987022,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-28T21:06:25.000Z","date":"2023-02-22","kind":"sale","acquired":false,"shares":47888,"price":34.7,"value":1661713.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.25 to $35.25, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7532710,"source":{"system":"sec-edgar","filing":"0000899243-23-006394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323006394/doc4.xml","form_type":"4"}},{"id":1993197,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-24T21:13:58.000Z","date":"2023-02-23","kind":"sale","acquired":false,"shares":1111,"price":36.24,"value":40262.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.15 to $36.36, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7580598,"source":{"system":"sec-edgar","filing":"0000899243-23-006123","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323006123/doc4.xml","form_type":"4"}},{"id":1993196,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-24T21:13:58.000Z","date":"2023-02-23","kind":"sale","acquired":false,"shares":48889,"price":35.55,"value":1738003.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.14 to $36.14, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7581709,"source":{"system":"sec-edgar","filing":"0000899243-23-006123","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323006123/doc4.xml","form_type":"4"}},{"id":1993195,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-24T21:13:58.000Z","date":"2023-02-22","kind":"sale","acquired":false,"shares":10084,"price":36.34,"value":366452.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.21 to $36.52, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7630598,"source":{"system":"sec-edgar","filing":"0000899243-23-006123","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323006123/doc4.xml","form_type":"4"}},{"id":1993194,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-24T21:13:58.000Z","date":"2023-02-22","kind":"sale","acquired":false,"shares":39916,"price":35.91,"value":1433383.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.20, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":7640682,"source":{"system":"sec-edgar","filing":"0000899243-23-006123","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323006123/doc4.xml","form_type":"4"}},{"id":2028101,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T21:11:26.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":40000,"price":6.883,"value":275320.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.82 to $7.08, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5447993,"source":{"system":"sec-edgar","filing":"0000899243-23-004187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323004187/doc4.xml","form_type":"4"}},{"id":2028100,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T21:11:26.000Z","date":"2023-02-03","kind":"sale","acquired":false,"shares":25000,"price":7.146,"value":178650.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.065 to $7.44, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5487993,"source":{"system":"sec-edgar","filing":"0000899243-23-004187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323004187/doc4.xml","form_type":"4"}},{"id":2032234,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T21:32:48.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":50000,"price":7.19,"value":359500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.93 to $7.32, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5512993,"source":{"system":"sec-edgar","filing":"0000899243-23-003869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323003869/doc4.xml","form_type":"4"}},{"id":2032233,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T21:32:48.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":40000,"price":6.95,"value":278000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.805 to $7.19, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5562993,"source":{"system":"sec-edgar","filing":"0000899243-23-003869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323003869/doc4.xml","form_type":"4"}},{"id":2038280,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-01T21:07:02.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":30000,"price":7.08,"value":212400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.92 to $7.18, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5602993,"source":{"system":"sec-edgar","filing":"0000899243-23-003120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323003120/doc4.xml","form_type":"4"}},{"id":2038279,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-01T21:07:02.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":30000,"price":6.91,"value":207300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.69 to $7.03, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5632993,"source":{"system":"sec-edgar","filing":"0000899243-23-003120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323003120/doc4.xml","form_type":"4"}},{"id":2043508,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-27T21:17:57.000Z","date":"2023-01-25","kind":"sale","acquired":false,"shares":50000,"price":6.85,"value":342500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.77 to $6.96, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5662993,"source":{"system":"sec-edgar","filing":"0000899243-23-002854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323002854/doc4.xml","form_type":"4"}},{"id":2046213,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T23:17:20.000Z","date":"2023-01-24","kind":"sale","acquired":false,"shares":80000,"price":6.98,"value":558400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $7.095, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5712993,"source":{"system":"sec-edgar","filing":"0000899243-23-002677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323002677/doc4.xml","form_type":"4"}},{"id":2046212,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T23:17:20.000Z","date":"2023-01-23","kind":"sale","acquired":false,"shares":80000,"price":6.81,"value":544800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.29 to $7.02, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5792993,"source":{"system":"sec-edgar","filing":"0000899243-23-002677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323002677/doc4.xml","form_type":"4"}},{"id":2050462,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T21:12:41.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":6114,"price":6.79,"value":41514.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.44 to $6.84, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5872993,"source":{"system":"sec-edgar","filing":"0000899243-23-002157","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323002157/doc4.xml","form_type":"4"}},{"id":2053569,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-17T21:28:42.000Z","date":"2023-01-13","kind":"sale","acquired":false,"shares":1971,"price":7.15,"value":14092.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.61 to $7.37, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5879107,"source":{"system":"sec-edgar","filing":"0000899243-23-001846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323001846/doc4.xml","form_type":"4"}},{"id":2053568,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-17T21:28:42.000Z","date":"2023-01-12","kind":"sale","acquired":false,"shares":5000,"price":6.77,"value":33850.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.985 to $6.92, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5881078,"source":{"system":"sec-edgar","filing":"0000899243-23-001846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323001846/doc4.xml","form_type":"4"}},{"id":2056288,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-11T21:09:32.000Z","date":"2022-10-18","kind":"gift","acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5931740,"source":{"system":"sec-edgar","filing":"0000899243-23-001583","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323001583/doc5.xml","form_type":"5"}},{"id":2056477,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-11T21:07:27.000Z","date":"2022-09-23","kind":"gift","acquired":false,"shares":833333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7680598,"source":{"system":"sec-edgar","filing":"0000899243-23-001580","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323001580/doc5.xml","form_type":"5"}},{"id":2056476,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-11T21:07:27.000Z","date":"2022-09-20","kind":"gift","acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8513931,"source":{"system":"sec-edgar","filing":"0000899243-23-001580","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323001580/doc5.xml","form_type":"5"}},{"id":2056475,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-11T21:07:27.000Z","date":"2022-09-12","kind":"gift","acquired":false,"shares":340000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8547264,"source":{"system":"sec-edgar","filing":"0000899243-23-001580","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323001580/doc5.xml","form_type":"5"}},{"id":2056474,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-11T21:07:27.000Z","date":"2022-09-12","kind":"gift","acquired":false,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8887264,"source":{"system":"sec-edgar","filing":"0000899243-23-001580","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323001580/doc5.xml","form_type":"5"}},{"id":2058463,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T21:08:06.000Z","date":"2023-01-06","kind":"sale","acquired":false,"shares":3000,"price":6.89,"value":20670.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.68 to $7.12, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5886078,"source":{"system":"sec-edgar","filing":"0000899243-23-001293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323001293/doc4.xml","form_type":"4"}},{"id":2058462,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T21:08:06.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":12162,"price":6.97,"value":84769.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.89 to $7.17, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5889078,"source":{"system":"sec-edgar","filing":"0000899243-23-001293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323001293/doc4.xml","form_type":"4"}},{"id":2061797,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T21:10:36.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":30000,"price":7.17,"value":215100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.91 to $7.28, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5901240,"source":{"system":"sec-edgar","filing":"0000899243-23-000979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323000979/doc4.xml","form_type":"4"}},{"id":2061796,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T21:10:36.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":500,"price":7.1,"value":3550.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.34, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5931240,"source":{"system":"sec-edgar","filing":"0000899243-23-000979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323000979/doc4.xml","form_type":"4"}},{"id":2061795,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T21:10:36.000Z","date":"2022-12-29","kind":"sale","acquired":false,"shares":25000,"price":7.1,"value":177500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.58 to $7.38, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":5931740,"source":{"system":"sec-edgar","filing":"0000899243-23-000979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924323000979/doc4.xml","form_type":"4"}},{"id":2141895,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-05T20:05:56.000Z","date":"2022-10-04","kind":"sale","acquired":false,"shares":3612,"price":8.8199,"value":31857.4788,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":6076740,"source":{"system":"sec-edgar","filing":"0000899243-22-032974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924322032974/doc4.xml","form_type":"4"}},{"id":2141894,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-05T20:05:56.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":28700,"price":8.779,"value":251957.3,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":6080352,"source":{"system":"sec-edgar","filing":"0000899243-22-032974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924322032974/doc4.xml","form_type":"4"}},{"id":2185326,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-15T22:48:12.000Z","date":"2022-08-11","kind":"purchase","acquired":true,"shares":3061224,"price":3.92,"value":11999998.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired by Morningside Venture Investments Limited (\"Morningside\") from the Issuer pursuant to a Subscription Agreement dated August 11, 2022."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside.  Ms. Richard, Ms. Franklin, Mr. Edwards and Mr. Cheung each disclaim beneficial ownership of the securities owned by Morningside and MVIL LLC (as defined below)."}],"balance_after":15919155,"source":{"system":"sec-edgar","filing":"0000899243-22-028680","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924322028680/doc4.xml","form_type":"4"}},{"id":2327476,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128991,"kind":"organization","name":"MVIL, LLC","position":2,"cik":"0001914583","reported_name":"MVIL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-2 Preferred Stock","published_at":"2022-03-17T21:14:49.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":1621544,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares of Series C-2 Preferred Stock and the Common Stock received upon conversion of the C-2 Preferred Stock are held by MVIL LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1621544},"source":{"system":"sec-edgar","filing":"0000899243-22-011432","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322011432/doc4a.xml","form_type":"4/A","original_submission_date":"2022-01-25"}},{"id":2327475,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128991,"kind":"organization","name":"MVIL, LLC","position":2,"cik":"0001914583","reported_name":"MVIL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2022-03-17T21:14:49.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":974107,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":974107},"source":{"system":"sec-edgar","filing":"0000899243-22-011432","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322011432/doc4a.xml","form_type":"4/A","original_submission_date":"2022-01-25"}},{"id":2327474,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128991,"kind":"organization","name":"MVIL, LLC","position":2,"cik":"0001914583","reported_name":"MVIL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2022-03-17T21:14:49.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":6410964,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6410964},"source":{"system":"sec-edgar","filing":"0000899243-22-011432","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322011432/doc4a.xml","form_type":"4/A","original_submission_date":"2022-01-25"}},{"id":2327473,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128991,"kind":"organization","name":"MVIL, LLC","position":2,"cik":"0001914583","reported_name":"MVIL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2022-03-17T21:14:49.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":1409035,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1409035},"source":{"system":"sec-edgar","filing":"0000899243-22-011432","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322011432/doc4a.xml","form_type":"4/A","original_submission_date":"2022-01-25"}},{"id":2327472,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128991,"kind":"organization","name":"MVIL, LLC","position":2,"cik":"0001914583","reported_name":"MVIL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-03-17T21:14:49.000Z","date":"2022-01-11","kind":"purchase","acquired":true,"shares":263158,"price":19,"value":5000002.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."}],"balance_after":10678808,"source":{"system":"sec-edgar","filing":"0000899243-22-011432","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322011432/doc4a.xml","form_type":"4/A","original_submission_date":"2022-01-25"}},{"id":2327471,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128991,"kind":"organization","name":"MVIL, LLC","position":2,"cik":"0001914583","reported_name":"MVIL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-03-17T21:14:49.000Z","date":"2022-01-11","kind":"exercise","acquired":true,"shares":10415650,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares of Series C-2 Preferred Stock and the Common Stock received upon conversion of the C-2 Preferred Stock are held by MVIL LLC."}],"balance_after":10415650,"source":{"system":"sec-edgar","filing":"0000899243-22-011432","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322011432/doc4a.xml","form_type":"4/A","original_submission_date":"2022-01-25"}},{"id":2326468,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128991,"kind":"organization","name":"MVIL, LLC","position":2,"cik":"0001914583","reported_name":"MVIL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-17T21:11:19.000Z","date":"2022-02-02","kind":"exercise","acquired":false,"shares":1000000,"price":10,"value":10000000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Richard, Ms. Franklin, Mr. Edwards and Mr. Cheung each disclaim beneficial ownership of the securities owned by Morningside and MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Represent shares held by MVIL LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000899243-22-011429","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924322011429/doc4a.xml","form_type":"4/A","original_submission_date":"2022-02-04"}},{"id":2326467,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128991,"kind":"organization","name":"MVIL, LLC","position":2,"cik":"0001914583","reported_name":"MVIL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-17T21:11:19.000Z","date":"2022-02-02","kind":"exercise","acquired":false,"shares":12857931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represent shares of Class A Common Stock received in exchange for shares of GreenLight BioSciences, Inc. (\"Greenlight\") in connection with the business combination transaction of the Issuer.  This amendment corrects the number of shares of Class A Common Stock received by Morningside upon conversion of Greenlight shares into Class A Common Stock of the Issuer.  The previous number of 12,858,188 has been revised to 12,857,936."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Richard, Ms. Franklin, Mr. Edwards and Mr. Cheung each disclaim beneficial ownership of the securities owned by Morningside and MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12857931},"source":{"system":"sec-edgar","filing":"0000899243-22-011429","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924322011429/doc4a.xml","form_type":"4/A","original_submission_date":"2022-02-04"}},{"id":2326466,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128991,"kind":"organization","name":"MVIL, LLC","position":2,"cik":"0001914583","reported_name":"MVIL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-03-17T21:11:19.000Z","date":"2022-02-02","kind":"purchase","acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Richard, Ms. Franklin, Mr. Edwards and Mr. Cheung each disclaim beneficial ownership of the securities owned by Morningside and MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Represent shares held by MVIL LLC."}],"balance_after":13857931,"source":{"system":"sec-edgar","filing":"0000899243-22-011429","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924322011429/doc4a.xml","form_type":"4/A","original_submission_date":"2022-02-04"}},{"id":2326465,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128991,"kind":"organization","name":"MVIL, LLC","position":2,"cik":"0001914583","reported_name":"MVIL, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-03-17T21:11:19.000Z","date":"2022-02-02","kind":"exercise","acquired":true,"shares":12857931,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Richard, Ms. Franklin, Mr. Edwards and Mr. Cheung each disclaim beneficial ownership of the securities owned by Morningside and MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."}],"balance_after":12857931,"source":{"system":"sec-edgar","filing":"0000899243-22-011429","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924322011429/doc4a.xml","form_type":"4/A","original_submission_date":"2022-02-04"}},{"id":2411376,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-02-04T22:15:10.000Z","date":"2022-02-02","kind":"exercise","acquired":false,"shares":1000000,"price":10,"value":10000000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Richard, Ms. Franklin, Mr. Edwards and Mr. Cheung each disclaim beneficial ownership of the securities owned by Morningside.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Represent shares held by MVIL LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000899243-22-004855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924322004855/doc4.xml","form_type":"4"}},{"id":2411375,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-02-04T22:15:10.000Z","date":"2022-02-02","kind":"exercise","acquired":false,"shares":12858188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represent shares of Class A Common Stock received in exchange for shares of GreenLight BioSciences, Inc. in connection with the business combination transaction of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Richard, Ms. Franklin, Mr. Edwards and Mr. Cheung each disclaim beneficial ownership of the securities owned by Morningside.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12858188},"source":{"system":"sec-edgar","filing":"0000899243-22-004855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924322004855/doc4.xml","form_type":"4"}},{"id":2411374,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-04T22:15:10.000Z","date":"2022-02-02","kind":"purchase","acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Richard, Ms. Franklin, Mr. Edwards and Mr. Cheung each disclaim beneficial ownership of the securities owned by Morningside.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Represent shares held by MVIL LLC."}],"balance_after":13858188,"source":{"system":"sec-edgar","filing":"0000899243-22-004855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924322004855/doc4.xml","form_type":"4"}},{"id":2411373,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-04T22:15:10.000Z","date":"2022-02-02","kind":"exercise","acquired":true,"shares":12858188,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's business combination transaction, all Class A Common Stock converted into the same number of shares of the Issuer's Common Stock without payment or further consideration. The Class A Common Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Richard, Ms. Franklin, Mr. Edwards and Mr. Cheung each disclaim beneficial ownership of the securities owned by Morningside.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."}],"balance_after":12858188,"source":{"system":"sec-edgar","filing":"0000899243-22-004855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000089924322004855/doc4.xml","form_type":"4"}},{"id":2426682,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-2 Preferred Stock","published_at":"2022-01-25T21:46:38.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":1621544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside and share voting and dispositive power with respect to the securities held by Morningside Venture Investments Limited (\"Morningside\") and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares of Series C-2 Preferred Stock and the Common Stock received upon conversion of the C-2 Preferred Stock are held by MVIL LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1621544},"source":{"system":"sec-edgar","filing":"0000899243-22-003157","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322003157/doc4.xml","form_type":"4"}},{"id":2426681,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2022-01-25T21:46:38.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":974107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside and share voting and dispositive power with respect to the securities held by Morningside Venture Investments Limited (\"Morningside\") and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":974107},"source":{"system":"sec-edgar","filing":"0000899243-22-003157","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322003157/doc4.xml","form_type":"4"}},{"id":2426680,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2022-01-25T21:46:38.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":6410964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside and share voting and dispositive power with respect to the securities held by Morningside Venture Investments Limited (\"Morningside\") and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6410964},"source":{"system":"sec-edgar","filing":"0000899243-22-003157","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322003157/doc4.xml","form_type":"4"}},{"id":2426679,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2022-01-25T21:46:38.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":1409035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside and share voting and dispositive power with respect to the securities held by Morningside Venture Investments Limited (\"Morningside\") and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1409035},"source":{"system":"sec-edgar","filing":"0000899243-22-003157","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322003157/doc4.xml","form_type":"4"}},{"id":2426678,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-25T21:46:38.000Z","date":"2022-01-11","kind":"purchase","acquired":true,"shares":263158,"price":19,"value":5000002.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside and share voting and dispositive power with respect to the securities held by Morningside Venture Investments Limited (\"Morningside\") and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."}],"balance_after":10678808,"source":{"system":"sec-edgar","filing":"0000899243-22-003157","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322003157/doc4.xml","form_type":"4"}},{"id":2426677,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-25T21:46:38.000Z","date":"2022-01-11","kind":"exercise","acquired":true,"shares":10415650,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the \"Preferred Stock\") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside and share voting and dispositive power with respect to the securities held by Morningside Venture Investments Limited (\"Morningside\") and MVIL, LLC (\"MVIL LLC\"), Morningside's wholly-owned subsidiary.  Cheng Yee Wing and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC.  Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares of Series C-2 Preferred Stock and the Common Stock received upon conversion of the C-2 Preferred Stock are held by MVIL LLC."}],"balance_after":10415650,"source":{"system":"sec-edgar","filing":"0000899243-22-003157","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322003157/doc4.xml","form_type":"4"}},{"id":2504730,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-18T21:16:40.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":250000,"price":40,"value":10000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Frances Anne Elizabeth Richard, Cheung Ka Ho, Jill Marie Franklin and Peter Stuart Allenby Edwards, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":12806342,"source":{"system":"sec-edgar","filing":"0000899243-21-045265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000089924321045265/doc4.xml","form_type":"4"}},{"id":3286237,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-06T21:11:01.000Z","date":"2020-02-04","kind":"purchase","acquired":true,"shares":3800000,"price":2.6,"value":9880000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":6109052,"source":{"system":"sec-edgar","filing":"0001104659-20-011907","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000110465920011907/a4.xml","form_type":"4"}},{"id":3306393,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-21T22:47:39.000Z","date":"2020-01-13","kind":"purchase","acquired":true,"shares":540540,"price":37,"value":19999980.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":12556342,"source":{"system":"sec-edgar","filing":"0000899243-20-001530","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000089924320001530/doc4.xml","form_type":"4"}},{"id":3597064,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-13T19:32:09.000Z","date":"2019-03-11","kind":"purchase","acquired":true,"shares":441176,"price":17,"value":7499992.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":12015802,"source":{"system":"sec-edgar","filing":"0001104659-19-014545","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000110465919014545/a4.xml","form_type":"4"}},{"id":3809074,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-24T22:05:08.000Z","date":"2018-09-21","kind":"purchase","acquired":true,"shares":40000,"price":19.84,"value":793600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price is a weighted average price. These shares were purchased on 9/21/2018 in multiple transactions at prices ranging from $19.48 to $20.14, inclusive. The reporting person undertakes to provide to Apellis Pharmaceuticals, Inc., any security holder of Apellis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":11574626,"source":{"system":"sec-edgar","filing":"0000899243-18-025079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000089924318025079/doc4.xml","form_type":"4"}},{"id":3809073,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-24T22:05:08.000Z","date":"2018-09-20","kind":"purchase","acquired":true,"shares":21724,"price":19.43,"value":422097.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average price. These shares were purchased on 9/20/2018 in multiple transactions at prices ranging from $19.25 to $19.60, inclusive. The reporting person undertakes to provide to Apellis Pharmaceuticals, Inc., any security holder of Apellis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":11534626,"source":{"system":"sec-edgar","filing":"0000899243-18-025079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000089924318025079/doc4.xml","form_type":"4"}},{"id":3809072,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-24T22:05:08.000Z","date":"2018-09-20","kind":"purchase","acquired":true,"shares":19599,"price":18.79,"value":368265.21,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average price. These shares were purchased on 9/20/2018 in multiple transactions at prices ranging from $18.25 to $19.24, inclusive. The reporting person undertakes to provide to Apellis Pharmaceuticals, Inc., any security holder of Apellis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":11512902,"source":{"system":"sec-edgar","filing":"0000899243-18-025079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000089924318025079/doc4.xml","form_type":"4"}},{"id":3811577,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-19T23:42:01.000Z","date":"2018-09-19","kind":"purchase","acquired":true,"shares":60000,"price":18.09,"value":1085400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price is a weighted average price. These shares were purchased on 9/19/2018 in multiple transactions at prices ranging from $17.81 to $18.44, inclusive. The reporting person undertakes to provide to Apellis Pharmaceuticals, Inc., any security holder of Apellis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":11493303,"source":{"system":"sec-edgar","filing":"0000899243-18-024796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000089924318024796/doc4.xml","form_type":"4"}},{"id":3811576,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-19T23:42:01.000Z","date":"2018-09-18","kind":"purchase","acquired":true,"shares":40000,"price":18.47,"value":738800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price is a weighted average price. These shares were purchased on 9/18/2018 in multiple transactions at prices ranging from $18.23 to $18.96, inclusive. The reporting person undertakes to provide to Apellis Pharmaceuticals, Inc., any security holder of Apellis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":11433303,"source":{"system":"sec-edgar","filing":"0000899243-18-024796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000089924318024796/doc4.xml","form_type":"4"}},{"id":3811575,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-19T23:42:01.000Z","date":"2018-09-17","kind":"purchase","acquired":true,"shares":8600,"price":18.84,"value":162024.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average price. These shares were purchased on 9/17/2018 in multiple transactions at prices ranging from $18.75 to $18.99, inclusive. The reporting person undertakes to provide to Apellis Pharmaceuticals, Inc., any security holder of Apellis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":11393303,"source":{"system":"sec-edgar","filing":"0000899243-18-024796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000089924318024796/doc4.xml","form_type":"4"}},{"id":3811574,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-19T23:42:01.000Z","date":"2018-09-17","kind":"purchase","acquired":true,"shares":31400,"price":18.5,"value":580900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average price. These shares were purchased on 9/17/2018 in multiple transactions at prices ranging from $17.75 to $18.74, inclusive. The reporting person undertakes to provide to Apellis Pharmaceuticals, Inc., any security holder of Apellis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":11384703,"source":{"system":"sec-edgar","filing":"0000899243-18-024796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000089924318024796/doc4.xml","form_type":"4"}},{"id":3856591,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase Common Stock","published_at":"2018-08-01T17:14:01.000Z","date":"2018-07-30","kind":"other","acquired":true,"shares":18996,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Immediately prior to the closing of the Issuer's initial public offering and without payment of further consideration, the Warrants to purchase Series D Preferred Stock automatically became exercisable to purchase the Issuer's common stock. The transaction is listed solely for the purpose of reporting the change of the title and amount of securities underlying the warrant."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the closing of the Issuer's initial public offering and without payment of further consideration, the Warrants to purchase Series D Preferred Stock automatically became exercisable to purchase the Issuer's common stock. The transaction is listed solely for the purpose of reporting the change of the title and amount of securities underlying the warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":18996,"derivative":{"exercise_price":0.01,"exercise_date":"2017-01-09","expiration_date":"2026-12-31","underlying":"Common Stock","underlying_shares":18996},"source":{"system":"sec-edgar","filing":"0001104659-18-048810","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1330436/000110465918048810/a4.xml","form_type":"4"}},{"id":3856590,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase Series D Preferred Stock","published_at":"2018-08-01T17:14:01.000Z","date":"2018-07-30","kind":"other","acquired":false,"shares":319664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Immediately prior to the closing of the Issuer's initial public offering and without payment of further consideration, the Warrants to purchase Series D Preferred Stock automatically became exercisable to purchase the Issuer's common stock. The transaction is listed solely for the purpose of reporting the change of the title and amount of securities underlying the warrant."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the closing of the Issuer's initial public offering and without payment of further consideration, the Warrants to purchase Series D Preferred Stock automatically became exercisable to purchase the Issuer's common stock. The transaction is listed solely for the purpose of reporting the change of the title and amount of securities underlying the warrant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":0,"derivative":{"exercise_price":0.01,"exercise_date":"2017-01-09","expiration_date":"2026-12-31","underlying":"Series D Preferred Stock","underlying_shares":319664},"source":{"system":"sec-edgar","filing":"0001104659-18-048810","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1330436/000110465918048810/a4.xml","form_type":"4"}},{"id":3856589,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2018-08-01T17:14:01.000Z","date":"2018-07-30","kind":"exercise","acquired":false,"shares":1849490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series D preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0594-for-1 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series D preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0594-for-1 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series D preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0594-for-1 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":109909},"source":{"system":"sec-edgar","filing":"0001104659-18-048810","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1330436/000110465918048810/a4.xml","form_type":"4"}},{"id":3856588,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-08-01T17:14:01.000Z","date":"2018-07-30","kind":"exercise","acquired":false,"shares":3420516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":442819},"source":{"system":"sec-edgar","filing":"0001104659-18-048810","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1330436/000110465918048810/a4.xml","form_type":"4"}},{"id":3856587,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-01T17:14:01.000Z","date":"2018-07-30","kind":"exercise","acquired":true,"shares":109909,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series D preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0594-for-1 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":552728,"source":{"system":"sec-edgar","filing":"0001104659-18-048810","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1330436/000110465918048810/a4.xml","form_type":"4"}},{"id":3856586,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-01T17:14:01.000Z","date":"2018-07-30","kind":"exercise","acquired":true,"shares":442819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":442819,"source":{"system":"sec-edgar","filing":"0001104659-18-048810","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1330436/000110465918048810/a4.xml","form_type":"4"}},{"id":3882014,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-06-27T20:53:20.000Z","date":"2018-06-25","kind":"exercise","acquired":false,"shares":1007422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1007422},"source":{"system":"sec-edgar","filing":"0001209191-18-039676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000120919118039676/doc4.xml","form_type":"4"}},{"id":3882013,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2018-06-27T20:53:20.000Z","date":"2018-06-25","kind":"exercise","acquired":false,"shares":1051630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1051630},"source":{"system":"sec-edgar","filing":"0001209191-18-039676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000120919118039676/doc4.xml","form_type":"4"}},{"id":3882012,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-27T20:53:20.000Z","date":"2018-06-25","kind":"purchase","acquired":true,"shares":250000,"price":15,"value":3750000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":2309052,"source":{"system":"sec-edgar","filing":"0001209191-18-039676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000120919118039676/doc4.xml","form_type":"4"}},{"id":3882011,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-27T20:53:20.000Z","date":"2018-06-25","kind":"exercise","acquired":true,"shares":1007422,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":2059052,"source":{"system":"sec-edgar","filing":"0001209191-18-039676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000120919118039676/doc4.xml","form_type":"4"}},{"id":3882010,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-27T20:53:20.000Z","date":"2018-06-25","kind":"exercise","acquired":true,"shares":1051630,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments Limited (\"MVIL\"), share voting and dispositive control over the shares held by MVIL."}],"balance_after":1051630,"source":{"system":"sec-edgar","filing":"0001209191-18-039676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543112/000120919118039676/doc4.xml","form_type":"4"}},{"id":4165580,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2017-11-13T21:26:06.000Z","date":"2017-11-13","kind":"exercise","acquired":false,"shares":259302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":121566},"source":{"system":"sec-edgar","filing":"0000899243-17-026032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000089924317026032/doc4.xml","form_type":"4"}},{"id":4165579,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2017-11-13T21:26:06.000Z","date":"2017-11-13","kind":"exercise","acquired":false,"shares":4476275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2098581},"source":{"system":"sec-edgar","filing":"0000899243-17-026032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000089924317026032/doc4.xml","form_type":"4"}},{"id":4165578,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2017-11-13T21:26:06.000Z","date":"2017-11-13","kind":"exercise","acquired":false,"shares":17200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8063759},"source":{"system":"sec-edgar","filing":"0000899243-17-026032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000089924317026032/doc4.xml","form_type":"4"}},{"id":4165577,"issuer":{"id":47322,"kind":"organization","name":"Apellis Pharmaceuticals, Inc.","symbol":"APLS"},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2017-11-13T21:26:06.000Z","date":"2017-11-13","kind":"exercise","acquired":false,"shares":1054544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":494394},"source":{"system":"sec-edgar","filing":"0000899243-17-026032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492422/000089924317026032/doc4.xml","form_type":"4"}}],"next_cursor":"2017-11-13T21:26:06.000000Z,4165577"}